Inventor · disambiguated record
Karl A. Scheidt
Also filed as: SCHEIDT KARL · SCHEIDT KARL A
35 granted patents·7 pending applications·208 citations·filing 2008–2024
97Inventor score
Files withUNIV NORTHWESTERN37BERGAN RAYMOND C2DOW GLOBAL TECHNOLOGIES LLC1SCHEIDT KARL1SCHEIDT KARL A1
Top patents by PatentIndex Score
42 records- 0196US9840487B2Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compoundsUNIV NORTHWESTERN·Filed 2017·Granted Dec 12, 2017·10 cites·2 claims
- 0295US10781172B2Catalysts and methods for enantioselective conjugate additions of amines to unsaturated electrophilesUNIV NORTHWESTERN·Filed 2019·Granted Sep 22, 2020·7 cites·20 claims
- 0395US10654865B2Enantioselective syntheses of heteroyohimbine natural product intermediatesUNIV NORTHWESTERN·Filed 2019·Granted May 19, 2020·7 cites·7 claims
- 0495US10323039B2Enantioselective syntheses of heteroyohimbine natural product intermediatesUNIV NORTHWESTERN·Filed 2016·Granted Jun 18, 2019·11 cites·5 claims
- 0595US9309217B2Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compoundsUNIV NORTHWESTERN·Filed 2015·Granted Apr 12, 2016·11 cites·13 claims
- 0694US10308624B2Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compoundsUNIV NORTHWESTERN·Filed 2017·Granted Jun 4, 2019·8 cites·3 claims
- 0794US9624190B2Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compoundsUNIV NORTHWESTERN·Filed 2016·Granted Apr 18, 2017·9 cites·5 claims
- 0894US9512146B2Azolium metal-organic frameworksUNIV NORTHWESTERN·Filed 2015·Granted Dec 6, 2016·7 cites·6 claims
- 0994US8742141B2Inhibition and treatment of prostate cancer metastasisUNIV NORTHWESTERN·Filed 2013·Granted Jun 3, 2014·12 cites·16 claims
- 1093US9334297B2Chiral imidazolium salts for asymmetric catalysisUNIV NORTHWESTERN·Filed 2015·Granted May 10, 2016·10 cites·8 claims
- 1192US10231949B2Inhibition of cancer cell motilityUNIV NORTHWESTERN·Filed 2017·Granted Mar 19, 2019·10 cites·6 claims
- 1292US9260564B2Catalyst for non-isocyanate based polyurethaneDOW GLOBAL TECHNOLOGIES LLC·Filed 2015·Granted Feb 16, 2016·20 cites·6 claims
- 1391US9839625B2Inhibition of cancer cell motilityUNIV NORTHWESTERN·Filed 2015·Granted Dec 12, 2017·10 cites·12 claims
- 1491US9527812B2N-heterocyclic carbene-catalyzed synthesis of 2-aryl indolesUNIV NORTHWESTERN·Filed 2015·Granted Dec 27, 2016·10 cites·25 claims
- 1588US11518750B23-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomeraseUNIV NORTHWESTERN·Filed 2020·Granted Dec 6, 2022·2 cites·16 claims
- 1688US10780076B2Inhibition of cancer cell motilityUNIV NORTHWESTERN·Filed 2019·Granted Sep 22, 2020·5 cites·15 claims
- 1787US9981968B2Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disordersUNIV NORTHWESTERN·Filed 2015·Granted May 29, 2018·14 cites·18 claims
- 1887US8912341B2Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinonesUNIV NORTHWESTERN·Filed 2014·Granted Dec 16, 2014·10 cites·20 claims
- 1986US9643947B27-membered fused heterocycles and methods of their synthesisUNIV NORTHWESTERN·Filed 2014·Granted May 9, 2017·10 cites·4 claims
- 2085US7851640B2Catalytic enantioselective synthesis of flavanones and chromanonesUNIV NORTHWESTERN·Filed 2009·Granted Dec 14, 2010·9 cites·17 claims
- 2184US9090634B2Azolium metal-organic frameworksSCHEIDT KARL A·Filed 2013·Granted Jul 28, 2015·5 cites·4 claims
- 2283US12440476B2Agents that target telomerase reverse transcriptase (TERT) for treating cancer and sensitizing cancer cells to genotoxic therapyUNIV NORTHWESTERN·Filed 2024·Granted Oct 14, 2025·0 cites·9 claims
- 2383US8481760B2Inhibition and treatment of prostate cancer metastasisBERGAN RAYMOND C·Filed 2009·Granted Jul 9, 2013·9 cites·2 claims
- 2479US11225483B2Substituted fused pyrrolo-diazepinones and uses thereofUNIV NORTHWESTERN·Filed 2019·Granted Jan 18, 2022·1 cites·14 claims
- 2572US11174238B2Enantioselective cross dehydrogenative coupling reactions and compounds synthesized by the reactionsUNIV NORTHWESTERN·Filed 2019·Granted Nov 16, 2021·1 cites·12 claims
- 2669US2009124569A1Inhibition and treatment of prostate cancer metastasisUNIV NORTHWESTERN·Filed 2008·Application pending·0 cites
- 2768US12435055B23-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitors of telomeraseUNIV NORTHWESTERN·Filed 2022·Granted Oct 7, 2025·0 cites·4 claims
- 2868US12410149B2Substituted chromanes, analogs thereof, and methods of use and synthesisUNIV NORTHWESTERN·Filed 2023·Granted Sep 9, 2025·0 cites·17 claims
- 2968US12252492B2Substituted fused pyrrolo-diazepinones and uses thereofUNIV NORTHWESTERN·Filed 2022·Granted Mar 18, 2025·0 cites·12 claims
- 3067US11840514B2Catalysts and methods for enantioselective conjugate addition of amines to unsaturated electrophilesUNIV NORTHWESTERN·Filed 2020·Granted Dec 12, 2023·0 cites·7 claims
- 3166US2024109903A1Substituted heterocycles for treating cancerUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 3265US11691958B2Enantioselective cross dehydrogenative coupling reactions and compounds synthesized by the reactionsUNIV NORTHWESTERN·Filed 2021·Granted Jul 4, 2023·0 cites·5 claims
- 3364US2023265093A1Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c)UNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 3462US2025049791A1Synthesis of MEK7 Inhibitors and methods of Use ThereofUNIV NORTHWESTERN·Filed 2024·Application pending·0 cites
- 3561US11485734B2Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT2C)UNIV NORTHWESTERN·Filed 2019·Granted Nov 1, 2022·0 cites·16 claims
- 3659US11639340B2Substituted chromanes, analogs thereof, and methods of use and synthesisUNIV NORTHWESTERN·Filed 2020·Granted May 2, 2023·0 cites·21 claims
- 3758US2024116875A1Rational design, optimization, and biological evaluation of novel mek4 inhibitors against pancreatic adenocarcinomaUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 3852US11440892B2Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesisUNIV NORTHWESTERN·Filed 2020·Granted Sep 13, 2022·0 cites·19 claims
- 3952US2012283313A1Inhibition and treatment of prostate cancer metastasisBERGAN RAYMOND C·Filed 2012·Application pending·0 cites
- 4049US11370770B23-arylindazoles as selective MEK4 inhibitorsUNIV NORTHWESTERN·Filed 2020·Granted Jun 28, 2022·0 cites·25 claims
- 4147US11479558B2Substituted tetrahydropyranoindoles, derivatives thereof, and their methods of synthesis and useUNIV NORTHWESTERN·Filed 2020·Granted Oct 25, 2022·0 cites·27 claims
- 4242US2011117649A1Catalytic enantioselective synthesis of flavanones and chromanonesSCHEIDT KARL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl A. Scheidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →